Skip to main content
Premium Trial:

Request an Annual Quote

GVK Biosciences Licenses Biomarker Database to NCI

NEW YORK (GenomeWeb News) – Indian contract research organization GVK Biosciences today announced the licensing of its clinical biomarker database to the National Institutes of Health's National Cancer Institute.

The database called GOBIOM is being licensed to NCI's Division of Cancer Prevention. Financial and other terms of the deal were not disclosed.

GOBIOM comprises all clinically evaluated exploratory and preclinical biomarkers that are associated with therapeutic areas reported in clinical trials, as well as clinical and preclinical studies that have been conducted worldwide, GVK said. It contains data for 15,500 biochemical, genomic, imaging, metabolite, cellular and physiological biomarkers with multiple data points covering experimental, analytical, clinical, preclinical, and statistical data with their qualifications under different medical interventions.

GOBIOM covers more than 100 different ethnicities, GVK Biosciences added, providing information on approved assay methodologies and companion diagnostics, and it has more than 6,000 clinically evaluated cancer biomarkers.

GVK is based in Hyderabad, India and provides stand-alone and integrated services covering R&D processes.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.